logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
严

严茂林 (Mao-Lin Yan)

fuzhou university affiliated provincial hospital肝胆胰外科工作邮箱:yanmaolin74@163.com
H指数:18
被引数:1,149

个人简介

暂无内容

教育背景

  • 2001.01 – 2006.12

    四川大学华西临床医学院 硕博阶段学习

  • 1993.01 – 1998.12

    赣南医学院 本科阶段学习

工作经历

  • 2006.01 – 至今

    福州大学附属省立医院

    肝胆胰外科工作

荣誉奖项

  1. 第五届福建省抗癌协会科技进步奖二等奖（2024）｜福建省抗癌协会
  2. 福建省科学技术进步奖三等奖（2025）｜福建省科学技术进步奖
Intratumoral CXCL13 + T follicular helper cells are associated with the formation and maturation of tertiary lymphoid structures in unresectable hepatocellular carcinoma treated with triple therapy

肿瘤内CXCL13⁺滤泡辅助性T细胞与接受三联疗法治疗的不可切除性肝细胞癌中三级淋巴结构的形成和成熟相关

Journal of Translational Medicine
IF7.5
2026-09-300
OAAI
Shuqun Li; Longkuan Xu; Zhenxin Zeng; Jiayi Wu; Shaoming Wei; Chaoyue Huang; Yinan Li; Houxiang Ya; Huachun Song; Jianhui Pan; Deyi Liu; Xiangye Ou; Jinhai Li; Junyi Wu; Maolin Yan
Hypertemperature-Detonated Biomimetic Semiconductor Stromal Bombs for Enhanced Immunotherapy in Pancreatic Cancer

高温-爆轰仿生半导体基质炸弹用于增强胰腺癌免疫治疗

Advanced Materials
IF26.8
2026-09-280
PRE
Chengke Xie; Houjuan Zhu; Jianfan Wen; Yichao Mo; Wanwan Wang; Chui Yu Chan; Xinquan Lin; Xiaoxiao Huang; Ge Li; Yongding Wu; Xiaotong Fan; Zheng Jie; Maolin Yan; Zhiyuan Li; Zuwei Wang; Jerry Zhi Xiong Heng; Karen Yuanting Tang; Yifeng Tian; Enyi Ye; Loh Xian Jun; Zibiao Li; Chengyu Liao; Shi Chen
Lenvatinib plus transarterial chemoembolization and PD-1 inhibitors as conversion therapies for unresectable intermediate-advanced hepatocellular carcinoma: a phase 2 trial and exploratory biomolecular study

Lenvatinib联合经动脉化疗栓塞和PD-1抑制剂作为不可切除的中晚期肝细胞癌的转换疗法: 一项2期试验和探索性生物分子研究

Signal Transduction and Targeted Therapy
IF52.7
2026-01-220
OAAI
Xiaoyun Zhang; Haozheng Cai; Wei Peng; Haiqing Wang; JiaYi Wu; Xinrui Zhu; Weixin Guo; Fei Xie; Yu Zhang; Ming Wang; Yu Yu; Yongjie Zhou; Chuan Li; Junyi Shen; Chang Liu; Yu Yang; Xiaozhong Jiang; Qiu Li; Weixia Chen; Yujun Shi; Wusheng Lu; Xin Sun; Xielin Feng; Maolin Yan; Shuqun Cheng; Tianfu Wen
Transarterial chemoembolization plus atezolizumab and bevacizumab in patients with intermediate hepatocellular carcinoma: a single-arm, phase 2 trial

经动脉化疗栓塞联合阿替利珠单抗和贝伐珠单抗治疗中期肝细胞癌患者：一项单臂、II期临床试验

Signal Transduction and Targeted Therapy
IF52.7
2025-10-060
OA
Kang Wang; Jinkai Feng; Hongming Yu; Yuqiang Cheng; Yanjun Xiang; Zonghan Liu; Yingyi Qin; Enyu Liu; Yunfeng Shan; Chen Fan; Jian Zhai; Dandan He; Hongkun Zhou; Yufu Tang; Jie Shi; Weixing Guo; Maolin Yan; Luowen Yu; Masatoshi Kudo; Shuqun Cheng
Long-term survival in advanced unresectable HCC treated with transcatheter arterial chemoembolization combined with lenvatinib and PD-1 inhibitors

晚期不可切除HCC患者接受经导管动脉化疗栓塞联合仑伐替尼和PD-1抑制剂治疗后的长期生存

ONCOLOGIST
IF4.2
2025-06-010
PRE
Zeng, Zhen-Xin; Song, Hua-Chun; Li, Yi-Nan; Wu, Jia-Yi; Liang, Dong; Li, Shu-Qun; Zhang, Zhi-Bo; Zhuang, Shao-Wu; Li, Bin; Zhou, Jian-Yin; Liu, De-Yi; Li, Han; Ou, Xiang-Ye; Pan, Rong-Jian; Wu, Jun-Yi; Yan, Mao-Lin
Predictors of short- and long-term survival in unresectable hepatocellular carcinoma (uHCC) treated with transcatheter arterial chemoembolization combined with lenvatinib plus PD-1 inhibitors: a multicenter retrospective study

不可切除肝细胞癌(uHCC)经导管动脉化疗栓塞联合仑伐替尼加PD-1抑制剂治疗后短期及长期生存的预测因素：一项多中心回顾性研究

LANCET REGIONAL HEALTH-WESTERN PACIFIC
IF8.1
2025-02-010
OAAI
Zeng, Zhen-Xin; Li, Yi-Nan; Song, Hua-Chun; Wu, Jia-Yi; Li, Shu-Qun; Zhang, Zhi-Bo; Zhuang, Shao-Wu; Li, Bin; Zhou, Jian-Yin; Liu, De-Yi; Li, Han; Ou, Xiang-Ye; Pan, Rong-Jian; Wu, Jun-Yi; Yan, Mao-Lin
Impact of Duration of Adjuvant Therapy on Patients with Initially Unresectable Hepatocellular Carcinoma After Conversion Surgery: A Propensity Score Matching Study

辅助治疗持续时间对初始不可切除肝细胞癌经转化手术治疗患者的影响：一项倾向评分匹配研究

JOURNAL OF HEPATOCELLULAR CARCINOMA
IF3.4
2024-09-010
OAAI
Lin, Zhong-Tai; Wei, Shao-Ming; Wu, Jun-Yi; Zhang, Zhi-Bo; Wang, Shuang-Jia; Zhou, Jian-Yin; Luo, Meng-Chao; Zeng, Zhen-Xin; Ou, Xiang-Ye; Fu, Yang-Kai; Li, Han; Liu, De-Yi; Wu, Jia-Yi; Yan, Mao-Lin

研究方向

联系邮箱：yanmaolin74@163.com
J
Jiayi Wu
H 指数:26论文数:238被引数:3,068
J
Jianyin Zhou
H 指数:17论文数:93被引数:1,027
Z
Zhi‐Bo Zhang
H 指数:10论文数:52被引数:444
Z
Zhen-Xin Zeng
H 指数:6论文数:20被引数:147
Y
Yinan Li
H 指数:22论文数:113被引数:1,571
J
Junyi Wu
H 指数:19论文数:107被引数:1,586
S
Shuqun Cheng
H 指数:52论文数:301被引数:9,688
J
Juxian Sun
H 指数:17论文数:97被引数:993
Y
Yannan Bai
H 指数:13论文数:80被引数:646
D
De-Yi Liu
H 指数:12论文数:47被引数:560